Wed, March 1, 2023
Tue, February 28, 2023
Mon, February 27, 2023

Steven Mah Initiated (ABCL) at Buy on, Feb 28th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -mah-initiated-abcl-at-buy-on-feb-28th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Steven Mah of Cowen & Co., Initiated "AbCellera Biologics Inc." (ABCL) at Buy on, Feb 28th, 2023.

Steven has made no other calls on ABCL in the last 4 months.



There are 5 other peers that have a rating on ABCL. Out of the 5 peers that are also analyzing ABCL, 0 agree with Steven's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Steven


  • Gary Nachman of "BMO Capital" Maintained at Buy with Decreased Target to $32 on, Wednesday, February 22nd, 2023
  • Tiago Fauth of "Credit Suisse" Reiterated at Buy and Held Target at $34 on, Wednesday, February 22nd, 2023
  • Puneet Souda of "SVB Leerink" Maintained at Buy with Decreased Target to $18 on, Friday, January 6th, 2023
  • Andrea Tan of "Goldman Sachs" Initiated at Strong Buy and Held Target at $30 on, Thursday, December 15th, 2022
  • Robyn Karnauskas of "Truist Securities" Initiated at Strong Buy and Held Target at $29 on, Wednesday, November 16th, 2022

Publication Contributing Sources